Long-form, data-driven studies on 1.6M+ filings across 43 markets. Comparative regulation, walk-forward backtests, profiles, market mechanics.
Biotech has outpaced the Nasdaq 100, but AstraZeneca has had no fresh company catalyst or insider filing in the last week.
Nestle hit a fresh 52-week high at 85.87 francs. Here is what the move says versus Danone, and why the insider record adds little today.
Five Superior Plus directors bought shares on July 17 as CNG growth and data center demand keep the propane distributor in focus.
Nestlé rose to 85.55 francs on July 17 as staples traded mixed. Here is the sector backdrop, the company news, and the insider record.
Algonquin Power drew clustered July 17 insider buys as utilities trade against higher yields, AI demand and a mixed peer set.
Curaleaf’s chief legal officer bought on July 17 as cannabis policy momentum, listed options, and peer activity frame the filing.
ABC Arbitrage’s major shareholder sold again in July. We read the filings against ECB rates, CAC 40 consolidation, and the firm’s arbitrage engine.
MCAN insiders bought on July 17 as Canada held rates at 2.25%. Here is how the cluster reads against mortgage peers and the renewal backdrop.
Jean-Paul Henri Lachance bought Peyto shares on July 17 as gas prices stayed soft, peers traded weakly, and the cluster widened.
HIVE Digital saw a EUR 278,989 insider buy as Bitcoin miners face post-halving margin pressure and AI pivots. Compare it with MARA, RIOT and CLSK.
ALTAREA drew a clustered insider buy of EUR 67,609 as French real estate steadies, rates ease and a new property tax bites.
Bayer has a Q1 beat, a June Supreme Court win and 1.97 million euros of net insider buying. Corteva is the cleaner peer check.